The HMTF Pilot Award Program for Myelodysplastic Syndrome Research

Funding Agency:
Taub Foundation

The new Henry and Marilyn Taub Foundation (HMTF) Pilot award will provide seed money to pursue transformative ideas that can forge new scientific directions and strategies in MDS research. The one-year award provides $100,000 for proof-of-concept studies addressing critical roadblocks to understanding MDS and its treatment. Successful projects will generate preliminary data needed to support their extension and expansion through other funding mechanisms. The research must be non-incremental and may include high-risk/high-reward or collaborative efforts to incorporate new technologies and approaches from other fields.


Required Letter of Intent: March 11, 2024

Invited Full Applications: July 1, 2024

Agency Website

Areas of Interest

1. The HMTF Pilot Award focuses specifically on non-incremental lines of inquiry based on novel and conceptually innovative ideas.
2. This program supports transformative basic and translational research focused specifically on MDS, exclusive of AML and MPN.
3. Clinical studies are outside of the program scope and timeframe.
4. MDS as defined by the World Health Organization (WHO), including CMML and JMML, are considered within the scope of research supported by the Taub Foundation.
5. Proposals studying the progression of MDS to AML may be within the scope of this funding, however, research primarily focused on AML, MPN or other malignancies is discouraged and all projects must be clearly relevant to MDS.

Eligibility Requirements

The award supports diversity and is dedicated to promoting independent early-career investigators. To foster innovation and the expansion of MDS research, collaborative efforts with those from non-MDS fields are encouraged. Do NOT apply unless you meet ALL of the Requirements and Research Criteria presented below.

  1. An MD, PhD, MD/PhD or equivalent degree is required.
  2. At the time of funding applicants must have a faculty appointment in the United States (instructor, assistant professor and above) with institution-designated laboratory space.
  3. Eligible organizations include non-profit public or private institutions, such as universities, colleges, hospitals, and laboratories in the United States.
  4. Neither United States citizenship or visa documentation is required.
  5. Applications from biotech, pharmaceutical and other for-profit industries are NOT eligible.
  6. Applicants must have the skills, knowledge, resources and infrastructure necessary to carry out the proposed research at their institution.
  7. Only one application per Principal Investigator is allowed.



Funding Type





Medical - Basic Science
Medical - Translational

External Deadline

March 11, 2024